Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Journal of Neuroengineering and Rehabilitation|October 14, 2024
Differing effectiveness of transcranial random noise stimulation and transcranial direct current stimulation for enhancing working memory in healthy individuals: a randomized controlled trialYukina Tokikuni, Akihiro Watanabe, Hisato Nakazono, et al.
Nature Materials|January 14, 2022
Hydride-ion-conducting K2NiF4-type Ba-Li oxyhydride solid electrolyteFumitaka Takeiri, Akihiro Watanabe, Kei Okamoto, et al.
Cells|January 8, 2023
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer ProgressionKota Yamada, Masafumi Saito, Masayuki Ando, et al.
International Journal of Hematology|July 5, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in JapanTakashi Taga, Toshihiko Imamura, Kentaro Nakashima, et al.
Anticancer Research|July 20, 2021
Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell CarcinomaKyosuke Agawa, Kimihiro Yamashita, Akio Nakagawa, et al.
Pediatric Blood & Cancer|October 21, 2015
Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study GroupHidemitsu Kurosawa, Akihiko Tanizawa, Chikako Tono, et al.
Pediatric Blood & Cancer|August 8, 2018
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study GroupHidemitsu Kurosawa, Akihiko Tanizawa, Hideki Muramatsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 6, 2009
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor ProgramHideki Muramatsu, Seiji Kojima, Ayami Yoshimi, et al.
International Journal of Hematology|March 15, 2025
Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor eraToshihide Yoshikawa, Hisashi Ishida, Akihiro Watanabe, et al.
Pediatric Blood & Cancer|April 11, 2022
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemiaHaruko Shima, Akiko Kada, Akihiko Tanizawa, et al.
Pageof 12